30 Jan 2017

N+1 Singer - Morning Song 30-01-2017

Renishaw plc (RSW:LON), 3,250 | Murgitroyd Group (MUR:LON), 0 | Waterman Group (WTM:LON), 0 | Realm Therapeutics (RLM:LON), 0 | Itaconix plc (ITX:LON), 130 | Conviviality (CVR:LON), 0 | RWS Holdings plc (RWS:LON), 87.0

- Singer CM Team
- 18 pages

ATTRAQT Group (ATQT LN) Reverse takeover of Fredhopper, £28.5m Firm Placing and Open Offer | Conviviality (CVR LN) Delivering against strategy | Murgitroyd Group (MUR LN) Recovery in prospect after H1 setback | Realm Therapeutics (RLM LN) IND filing for lead atopic dermatitis programme | Renishaw (RSW LN) H1 results in line; backdrop more supportive | Revolymer (REVO LN) Joint development agreement with Akzo Nobel | SDL (SDL LN) Fredhopper cash disposal for £25m | Waterman Group (WTM LN) Positi ....

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers

N+1 Singer - Morning Song 30-01-2017

Renishaw plc (RSW:LON), 3,250 | Murgitroyd Group (MUR:LON), 0 | Waterman Group (WTM:LON), 0 | Realm Therapeutics (RLM:LON), 0 | Itaconix plc (ITX:LON), 130 | Conviviality (CVR:LON), 0 | RWS Holdings plc (RWS:LON), 87.0

Published: 30 Jan 2017
Author: Singer CM Team
Pages: 18

ATTRAQT Group (ATQT LN) Reverse takeover of Fredhopper, £28.5m Firm Placing and Open Offer | Conviviality (CVR LN) Delivering against strategy | Murgitroyd Group (MUR LN) Recovery in prospect after H1 setback | Realm Therapeutics (RLM LN) IND filing for lead atopic dermatitis programme | Renishaw (RSW LN) H1 results in line; backdrop more supportive | Revolymer (REVO LN) Joint development agreement with Akzo Nobel | SDL (SDL LN) Fredhopper cash disposal for £25m | Waterman Group (WTM LN) Positi ....

Top